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ABSTRACT
The intrinsic factor is the major humoral autoantigen in pernicious anemia/
autoimmune gastritis. Although many studies have examined the autoantibody 
response to intrinsic factor and H+,K+-ATPase, no information is available on possible 
pathogenic mechanisms mediated by intrinsic factor - specific gastric T cells. Aim of 
this study was to investigate intrinsic factor-specific T cells in the gastric mucosa of 
pernicious anemia patients and define their functional properties. For the first time 
we provide evidence that gastric mucosa of pernicious anemia patients harbour a 
high proportion (20%) of autoreactive activated CD4+ T-cell clones that specifically 
recognize intrinsic factor. Most of these clones (94%) showed a T helper 17 or T 
helper 1 profile. All intrinsic factor-specific clones produced tumor necrosis factor-α, 
interleukin-21 and provided substantial help for B-cell immunoglobulin production. 
Most mucosa-derived intrinsic factor-specific T-cell clones expressed cytotoxicity 
against target cells. Our results indicate that activation of intrinsic factor-specific 
T helper 17 and T helper 1 T cells in the gastric mucosa represent a key effector 
mechanism in pernicious anemia suggesting that the T helper 17/T helper 1 pathway 
may represent a novel target for the prevention and treatment of the disease.
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INTRODUCTION
Pernicious anemia (PA) is an haematological 
disorder characterized by immunological and gastric 
pathologies [1, 2]. PA is an autoimmune disease 
consisting of gastric atrophy, macrocytic anemia, and 
reduction of parietal cells producing the intrinsic factor 
which is essential for vitamin B12 absorption. Vitamin 
B12 is required for erythropoietic process and synthesis 
of myelin [3]. The autoreactive process of PA proceeds 
during decades up to a severe state associated with a lack 
of vitamin B12 starting from a mild chronic autoimmune 
body gastritis (AIG). PA is usually characterized by 
anemia of the megaloblastic type and gastric atrophy 
which can be anticipated by neuropathies. The presence 
in PA of autoantibodies against intrinsic factor (secreted 
by the gastric parietal cells), and the coexistence in PA 
patients of other autoimmune disorders (e.g. autoimmune 
thyroiditis) support the immunopathological autoimmune 
bases of PA and AIG [4]. PA and AIG patients have 
documented both gastric mucosal infiltration of activated 
CD4+ T cells, macrophages and atrophy of the gastric 
corpus [5].
Intrinsic factor (IF) and gastric H+,K+-adenosine 
triphosphatase (ATPase) are crucial autoantigens 
recognized by autoreactive B cells and autoantibodies in 
PA patients [2, 6]. In experimental autoimmune gastritis 
(EAIG) the gastric H+,K+-ATPase is also the major 
autoantigen needed to elicit an organ-specific autoimmune 
disease [7–9]. In all the models of AIG H+,K+-ATPase 
stimulates both the production of autoantibodies and 
gastric inflammation, which is usually followed by loss of 
acid-secreting parietal cells and zymogenic cells [10, 11]. 
The immunohistopathologic lesions of EAIG (consisting 
of T and B cells, and macrophages) are very similar to 
those observed in patients with pernicious anemia [12]. No 
study have up to now unraveled the type of gastric T-cell 
responses specific for IF in PA.
We have characterized indeed in this research project 
the effector functions of T cells specific for intrinsic factor. 
Overall, we demonstrate that in PA patients, gastric-
derived T helper cells were able to secrete interferon 
gamma and interleukin 17 in response to IF and suggest 
that IF drives a local Th17/Th1 inflammatory response, 
which may represent a novel target for PA treatment.
RESULTS
Gastric mucosa of PA patients harbour 
autoreactive T helper cells specific for IF 
We studied activated T cells derived from the 
stomach of patients with PA. We recovered 265 T helper 
clones and 34 T suppressor clones from the gastric 
mucosae of 7 women affected with PA. We investigated 
at clonal level the proliferative responses in response to 
medium or IF, of all gastric PA-derived CD4+ and CD8+ T 
cells. No CD8+ T cells clone proliferated in response to IF 
although they showed proliferation to PHA.
20% (53) of gastric-derived CD4+ T cells showed 
proliferation to IF (Figure 1). Each PA patient displayed 
a comparable percentage of T helper cells proliferating 
to IF. On the other hand, we obtained 237 T helper and 
32 T suppressor clones from the stomach mucosae of 
Helicobacter-infected patients, seronegative for anti-
intrinsic factor antibody. We evaluated in all patients 
the proliferative response to IF of both gastric CD4+ 
and CD8+ T cells in MHC-restricted conditions. While 
CD4+ and CD8+ T cell clones were activated by PHA, 
none proliferated to IF. We have also investigated in PA 
patients the amount of T cells specific for IF present in 
the peripheral blood (pb) and compared it with the one 
found in the gastric mucosa. In the pb of PA patients the 
frequency of IF-specific T cells found in the peripheral 
blood ranged between 1:1800 and 1:3300 while in gastric 
mucosa it was remarkably higher (nearly 25%).
We also investigated the cytokine profile of gastric 
T cells specific for IF, using IF and autologous APCs and 
cytokine production was measured in supernatants. Upon 
antigen stimulation with IF, 28 IF-specific T-cell clones 
were polarized Th17 clones, 14 Th clones were polarized 
Th1, 9 Th clones were Th17/Th1 and only 2 were Th0 
clones (e.g. secreting both IL-4 and IFN-γ) (Figure 2). 
TNF-α was produced by nearly all T cells specific for IF. 
All 53 T helper clones specific for IF obtained 
from gastric mucosae of patients with PA were further 
screened by IFN-γ and IL-17 ELISPOT in response to 
IF. Upon appropriate antigen stimulation using ELISPOT 
specific and very sensitive technique, it is of note that 
thirty-seven gastric-derived CD4+ T cell clones produced 
IL-17, and twenty-five clones produced IFN-γ (Figure 3). 
Interestingly, all IL-17-producing IF-reactive T cell clones 
produce IL-21 (mean ± SE per 106 T cells was 3.4 ng/ml ± 
0.6) in response to antigen stimulation.
Helper function for antibody production by 
gastric-derived T cells specific for IF 
We evaluated the ability of T cells specific for IF to 
help antibody synthesis of B cells in the presence of IF in 
a 10 day T-B helper assay for antibody production. 
All the T cells specific for IF were able to help the 
antibody production by autologous B cells in the presence 
of IF (Figure 4). 
Gastric-derived IF-specific T cells display 
cytotoxicity against gastric mucosal cells and B 
cells
We evaluated the cytotoxicity of gastric-derived IF-
autoreactive T cells by testing the ability of each T-cell 
clone to kill either autologous B cells or gastric mucosal 
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MKN 28 cells. The perforin-related cytotoxicity was 
belonging to Th17, Th1 Th17/Th1, and Th0 T-cell clones 
(Figure 5A).
To assess if gastric T cells might exert killing of 
gastric epithelial cells, gastric mucosal cells such as MKN 
28 pulsed with intrinsic factor were used following co-
Figure 1: Proliferative response to IF of the IF-specific gastric CD4+ T cell clones obtained from PA patients. All the 
265 CD4+ and 34 CD8+ T cell clones obtained from the gastric mucosae of the 7 PA patients were assayed for proliferation in response to 
medium (o), or IF (10 nM) (■), in the presence of irradiated autologous presenting cells, by measuring [3H]thymidine uptake after 60 h 
of coculture. 53 CD4+ T-cell clones significantly proliferated to IF and their mitogenic index are shown in the figure. All the experiments 
have been performed in triplicates.
Figure 2: Cytokine profile of gastric IF-specific CD4+ T cell clones obtained from PA patients. Th clones were tested for 
cytokine production (A, B). IF-specific Th clones were stimulated with IF and IFN-γ and IL-17 TNF-α and IL-4, production was measured 
in culture supernatants. In unstimulated cultures, levels of IFN-γ and IL-17 TNF-α, IL-4, were consistently < 20 pg/ml. All the experiments 
have been performed in triplicates.
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cultured with 51Cr-MKN 28 and T cells (at an Effector/
Target ratio of 10 / 1 for 18 h in the presence of IF) (Figure 
5B). Upon IF activation, the 14 Th1, 23/28 Th17, 8/9 Th17/
Th1, and 1 out of 2 Th0 clones were able to induce death. 
DISCUSSION
The main findings of this work are that in the 
gastric mucosa of patients with pernicious anemia 
intrinsic factor: a) is able to drive T helper 17 and T helper 
1 T-cell responses; b) is capable to promote T-cell help 
for antibody production; c) activates T-cell cytotoxicity 
against gastric epithelial cells. The experimental approach 
used in this study has been successfully used in many 
other immunopathological conditions [13, 15–17]. Each 
PA patient, but not H. pylori-infected patient seronegative 
for IF, displayed in the gastric mucosa a significant 
proportion of gastric T cells specific for IF. Furthermore 
all PA patients, that were not infected by H. pylori, had 
no T cells specific for H. pylori in their gastric mucosae. 
Figure 3: IF driven IFN-γ and IL-17 secretion by IF-specific gastric derived Th clones from PA patients. Numbers of 
IFN-γ spot-forming cells (SFCs) after stimulation of gastric T cell clones with medium alone, or IF (A). T cell blasts from each clone were 
stimulated for 48 h with medium alone (o), or IF (■), in the presence of irradiated autologous APCs in ELISPOT microplates coated with 
anti-IFN-γ antibody. IFN-γ SFCs were then counted by using an automated reader. After specific stimulation, 25/53 IF-specific gastric T 
cell clones produced IFN-γ. Values are the mean ± SD number of SFCs per 105 cultured cells over background levels. All the experiments 
have been performed in triplicates. Numbers of IL-17 spot-forming cells SFCs after stimulation of gastric T cell clones with medium alone, 
or IF (B). T cell blasts from each clone were stimulated for 48 h with medium alone (o), or IF (■) in the presence of irradiated autologous 
APCs in ELISPOT microplates coated with anti-IL-17 antibody. IL-17 SFCs were then counted by using an automated reader. After 
specific stimulation 37/53 IF-specific gastric T cell clones produced IL-17. Values are the mean ± SD number of SFCs per 105 cultured 
cells over background levels.
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Figure 5: Cytotoxic activity of IF-specific gastric-derived T cells derived from PA patients. (A) To assess their cytotoxicity, 
IF-specific T cell clones were co-cultured at an effector-to-target ratio of 10 to 1 with 51Cr-labeled autologous EBV-B cells pulsed with 
IF (●) or medium (○) alone. 51Cr release was measured as index of specific target cell lysis. (B) To assess their ability to induce killing of 
gastric target cells, IF-specific T cell clones stimulated with IF (●) or medium (○) alone were co-cultured with 51Cr-labeled gastric MKN 
28 cells at an effector-to-target ratio of 10 to 1, and 51Cr release was measured as index of c target cell death.
Figure 4: Helper function of gastric IF-specific T cells derived from PA patients. Gastric IF-specific T cell clones help Ig 
production by autologous B cells. Autologous peripheral blood B cells (5 × 104) were co-cultured with IF-specific T cell blasts (5 × 104) in 
the absence (o) or presence of IF (■). After 10 days, cell free culture supernatants were harvested and tested for the presence of IgM, IgG, 
and IgA by ELISA. The results represent the mean (±SE) Ig levels induced by T cell clones over the spontaneous Ig production in cultures 
of B cell alone. All the experiments were done in triplicates.
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It is well known that IF is able to activate 
autoreactive B cells and their anti-IF autoantibody 
production. This study highlights that IF is not only able 
to promote IF-specific autoantibodies but also gastric 
T-cell inflammation. Gastric-derived T cells of PA patients 
were able to secrete many cytokines such as IL-17, IL-21, 
TNF-α and IFN-γ, but not interleukin 5 nor interleukin 
4. Using the same clonal experimental approach, a clear-
cut Th2 cytokine profile of T cells was found in parasitic 
infestations, such as in patients with Schistosoma mansoni 
infection [16, 18]. 
Furthermore we found that IF was able also to 
activate the helper function to B cells by T cells specific 
for IF, suggesting that the anti-IF autoantibody production 
might be at least in part favored by gastric mucosal T cell 
help to autologous B cells [19–23]. 
We also demonstrated that gastric-derived T cells 
specific for IF were able to kill both gastric mucosal cells 
and B cells, indicating that T-cell cytotoxicity is another 
important mechanism potentially leading to death of 
gastric epithelial cells and gastric atrophy. It is possible 
indeed to speculate that B7.1 and B7.2 might be up-
regulated by IFN-γ in gastric epithelial cells of PA patients 
and that those co-stimulatory molecules together with IL-
17, IL-21 and TNF-α might favor the continuous chronic 
activation of mucosal T cells in the stomach of PA patients 
[24]. It is of note that in PA patients there are high serum 
levels of TNF-α compared to healthy subjects [25].
Given that most of the IF-specific T cells found at 
gastric level secreted interleukin 21 and interleukin 17 we 
can speculate that Th17 cytokines are very important for 
driving gastric autoimmunity and autoantibody production 
in PA patients, as it is the case in many autoimmune 
diseases [21, 26–33]. We can hypothesize that different 
putative mechanisms of gastric damage might be activated 
by intrinsic factor-activated Th1 and Th17 T cells. Reports 
that gastric resident dendritic cells and different antigens, 
such as H. pylori, were able to activate T cells [34–38] 
suggest that resident gastric dendritic cells may also be 
implicated in the activation of intrinsic factor reactive T 
cells following activation by IF, as in other autoimmune 
pathologies [27, 30, 39–42]. 
In conclusion, our data provide evidence and 
indicate that activation of IF-specific Th17 and Th1 
effectors represent key components of disease in PA 
suggesting that the Th17/Th1 pathway may represent a 
novel therapeutic target for PA.
MATERIALS AND METHODS
Reagents
Human intrinsic factor was purchased by Prospec 
(Ness Ziona, Israel). Human recombinant (hr) interleukin 
(IL)-2 were provided by Novartis, Siena, Italy. PHA 
was purchased from Life Technologies (Carlsbad, CA). 
Fluorochrome-conjugated human monoclonal antibodies 
anti-CD3, anti-CD4, anti-CD8, anti-IFN-γ, anti-TNF-α, 
and isotype-matched control mAb were purchased from 
BD Biosciences (San Jose, CA, USA). The fluorochrome-
conjugated anti-IL-17 mAb was obtained from 
eBioscience (San Diego, CA, USA). PMA, ionomycin 
and brefeldin A were purchased from BD Biosciences (San 
Jose, CA, USA).
Patients
Upon approval of the local Ethical Committee, 
seven patients (5 females and 2 males, mean age 52; 
range 37–64 years) with PA and type A chronic AIG and 7 
patients (5 females and 2 males, mean age, 51; range, 38–
63 years) with Helicobacter pylori–induced uncomplicated 
type B chronic gastritis without atrophy (Hp-CG) were 
included in the present study. Diagnosis was made based 
on medical history, macrocytic anemia in peripheral blood, 
erythroblastosis with megaloblastic changes in bone 
marrow, low serum levels of vitamin B 12 and clinical 
responsiveness to vitamin B 12 therapy. All PA patients 
had serum intrinsic factor autoantibodies, as assessed by 
EliA (Thermo Fisher). All PA patients had negative results 
on both serology and 13C-urea breath test, which assess 
previous and/or actual H. pylori infection. The 7 control 
patients with Hp-CG were infected with CagA+VacA+H. 
pylori type I strains and were positive for anti-CagA serum 
immunoglobulin (Ig) G antibodies but they were negative 
for IF or other organ-specific autoantibodies. None of 
the patients had infections or inflammation. Following 
informed consent, biopsy specimens were obtained from 
the gastric mucosae and were used for diagnosis and 
culture of mucosa-infiltrating T lymphocytes.
Generation and characterization of gastric T cell 
clones
Biopsy specimens were cultured for 7 days in RPMI 
1640 medium supplemented with IL-2 (50 U/mL) to 
expand in vivo–activated T cells. Mucosal specimens were 
then disrupted, and single T-cell blasts were cloned under 
limiting dilution (0.3 cells/well), as described previously. 
To assess their phenotype profile, T cell clones were 
screened by flow cytometry with fluorochrome-conjugated 
anti-CD3, anti-CD4, anti-CD8 on a BD FACSCanto II 
(BD Bioscience), using the FACS Diva 6.1.3.software. 
Each clone was screened for responsiveness to IF (10 
μg/ml) by measuring [3H]thymidine uptake after 60 
hours of stimulation with medium, or IF in the presence 
of irradiated autologous mononuclear cells as antigen-
presenting cells (APCs). The mitogenic index (MI) was 
calculated as the ratio between mean values of counts per 
minute (cpm) obtained in stimulated cultures and those 
obtained in the presence of medium alone. MI >5 was 
considered as positive.
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Assessment of T cell clones cytokine profile
To assess the cytokine production of IF-specific T 
cell clones upon antigen stimulation, 5 × 105 T cell blasts 
of each clone were co-cultured for 48 h in 0.5 ml of serum-
free medium with 5 × 105 irradiated autologous PBMCs 
in the absence or presence of IF [13]. At the end of the 
culture period, duplicate samples of each supernatant were 
assayed for their IFN-γ, TNF-α, IL-4, IL-21 and IL-17 
(BioSource International, Camarillo, CA) production by 
ELISA. For further investigation, T cell blasts from each 
IF-specific T cell clone were stimulated with medium or 
IF (10 μg/ml) in the presence of autologous APCs for 48 
h in ELISPOT microplates coated with anti- IFN-γ or 
anti-IL-17 antibody, respectively (eBioscience, Inc., San 
Diego, Ca, USA). At the end of culture period, the number 
of IFN-γ and IL-17 SFCs were counted as described [21].
Evaluation of antigen-specific T cell-help for 
functional activation of autologous B cells
The cell culture system used for the induction 
of Ig synthesis was performed in duplicates tubes by 
using complete medium supplemented with 10% FCS, 
as described [14]. B cells (5 × 104) were cultured alone 
or with autologous clonal T cell blasts (5 × 104) in the 
absence or presence of IF antigen. After 10 days, culture 
supernatants were collected and assayed for their Ig 
content, as previously described [14].
T cell clone-mediated cytotoxicity
T cell clones cytolytic activity was assessed as 
reported [15]. T cell blasts of IF-specific T cell clones were 
incubated at ratios of 10 to 1 with 51Cr-labeled autologous 
Epstein-Barr virus transformed (EBV)-B cells pre-
incubated with IF (10 mg/ml) or medium alone or human 
albumin (5 μg/mL). After centrifugation, microplates were 
incubated for 8 h at 37° C, and 0.1 ml of supernatant was 
removed for the measurement of 51Cr release, as reported 
[15]. The ability of IF-specific T cell clones to induce death 
of gastric cells was assessed using gastric mucosal MKN 
28 cells as target, after activation of T cells with IF (10 mg/
ml)and autologous antigen presenting cells. T cell blasts 
from each clone were co-cultured with 51Cr-labeled MKN 
28 cells at an effector/target (E:T) ratio of 10 to 1 for 18 h. 
Statistical analysis
Student’s t-test was used for statistical analysis of 
the differences between experimental groups. P values less 
than or equal to 0.05 were considered significant.
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